帕金森病中的虹膜/PGC-1α/FNDC5通路:痛苦中的真相
Naif H Ali1, Nourah Ahmad Alhamdan2, Hayder M Al-Kuraishy3
1Department of Internal Medicine, Medical College, Najran University, Najran, Kingdom of Saudi Arabia.
Naunyn-Schmiedeberg's archives of pharmacology
|October 11, 2023
概括
虹膜激素通过减少炎症和氧化应激,对帕金森病 (PD) 产生神经保护作用. 这种激素可以通过素/PGC-1α/FNDC5通路预防多巴胺激素神经元损伤.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 生物化学 生物化学
背景情况:
- 帕金森病 (PD) 是一种常见的神经退行性疾病,其特征是α-synuclein聚合.
- 虹膜素是一种阿迪波金,因其在神经退行性疾病中的作用越来越受认可.
- 在PD神经病理学中了解虹膜素的功能对于开发新型治疗策略至关重要.
研究的目的:
- 审查虹膜激素在帕金森病 (PD) 神经病理学中的潜在作用.
- 阐明伊丽素在PD中发挥神经保护作用的机制.
- 要突出素/PGC-1α/FNDC5通路在PD中的重要性.
主要方法:
- 对研究伊丽素对神经退行过程的影响的文献综述.
- 分析伊丽素对参与PD的关键途径的影响,例如BDNF,PGC-1α和NF-κB.
- 检查虹膜素的抗炎,抗亡和抗氧化性质.
主要成果:
- 虹膜素通过增加脑衍生神经营养因子 (BDNF) 表达来表现神经保护作用.
- 虹膜素表现出抗炎,抗亡和抗氧化性质,减轻神经炎症.
- 虹膜素诱导的PGC-1α激活可以防止α-synuclein诱导的多巴胺类损伤和神经毒性.
结论:
- 虹膜激素通过抗炎和抗氧化机制在帕金森病 (PD) 中提供神经保护.
- 素/PGC-1α/FNDC5通路与预防多巴胺作用神经元损伤有关.
- 进一步的临床前和临床研究是有必要的,以探索伊丽素在PD的治疗潜力.
相关概念视频
01:15Parkinson's Disease: Overview
579
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
579
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:24Parkinson's Disease: Treatment
283
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
283
02:26NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K